<DOC>
	<DOCNO>NCT02184338</DOCNO>
	<brief_summary>Study ass safety , tolerability pharmacokinetics BIRB 1017 BS single rise oral dos 5 800 mg polyethylene glycol 400 ( PEG 400 ) / 26 % ethanol solution healthy male subject</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Single Rising Oral Doses BIRB 1017 BS Solution PEG 400 / 26 % Ethanol Administered Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ethanol</mesh_term>
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance Good Clinical Practice ( GCP ) local legislation Age &gt; = 18 &lt; = 50 year BMI &gt; 18.5 &lt; 29.9 kg/m2 ( Body Mass Index ) Any find medical examination ( include blood pressure , pulse rate , electrocardiogram ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , haematological , oncological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Relevant history orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug might influence result trial ( &lt; 10 day prior study drug administration expect trial ) Participation another trial investigational drug ( &lt; 2 month prior administration expect trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation loss &gt; 400 mL , &lt; 1 month prior administration expect trial Excessive physical activity ( within 5 day prior administration trial ) Clinically relevant laboratory abnormality Any electrocardiogram value outside reference range clinical relevance include , limited QRS interval &gt; 110 m QTcB &gt; 450 m QT &gt; 500 m Known hypersensitivity drug excipients Inability comply dietary regimen study centre Inability comply investigator 's instruction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>